HHMI
JNJ icon

Howard Hughes Medical Institute’s Johnson & Johnson JNJ Stock Holding History

Howard Hughes Medical Institute’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-520
Closed -$108K – 274
2025
Q4 		$108K Buy
520
+2
+0.4% +$395 0.06% 16
2025
Q3 		$96K Sell
518
-2
-0.4% -$343 0.06% 20
2025
Q2 		$79.4K Buy
+520
New +$79.9K 0.03% 21

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Howard Hughes Medical Institute's JNJ Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 520 shares — an estimated $108K sold.

Howard Hughes Medical Institute first reported a position in JNJ in Q2 2025 and held it in 3 quarters. The position peaked at $108K in Q4 2025. 4,623 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 520 Johnson & Johnson shares in Q1 2026, an estimated $108K.
  • Howard Hughes Medical Institute first reported a position in Johnson & Johnson in Q2 2025 and held it in 3 quarters.
  • Howard Hughes Medical Institute's Johnson & Johnson position peaked at $108K in Q4 2025.
  • 4,623 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.